Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Status Completed

Clinical Trial Summary

The purpose of this study is to identify subjects who are highly sensitized with antibodies. It is difficult for these patients to find suitable kidneys. We propose to treat such patients to decrease the antibodies in such a way, that it may become possible to safely transplant kidneys into them.

Clinical Trial Description

Kidney transplantation is the desired treatment of choice in subjects with end-stage kidney disease (ESRD). The average waiting time for subjects to receive a "deceased donor" kidney transplant is 3-5 years. Currently, there are about 60,000 subjects on the national waiting list, and about 13,000-14,000 kidney transplants are performed each year. Approximately, 25% of subjects on the waiting list are "highly sensitized", meaning that they have natural proteins (antibodies) that aggressively protect their bodies from the invasion of foreign proteins. These individuals often have a difficult time accepting transplanted kidneys. The purpose of this study is to identify subjects who are highly sensitized with these antibodies, and treat them in such a way, that it may become possible to transplant kidneys into them. Drugs like atorvastatin (Lipitor) may decrease the levels of these anti-bodies and increase the possibility of these subjects to receive a kidney transplant. This research study is being done because currently, there are very limited and cumbersome treatment options to address this issue, subjects who are highly sensitized with antibodies, may unfortunately wait for a very long time or may never get transplanted. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00143741
Study type	Interventional
Source	University of Chicago
Contact
Status	Completed
Phase	Phase 1
Start date	May 2005
Completion date	July 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02235571` - iChoose Decision Kidney Aid for End-Stage Renal Disease Patients	N/A
Active, not recruiting	`NCT05027074` - Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)	Phase 2
Completed	`NCT03582592` - Fluid Distribution Timetable on Adherence to Fluid Restriction of Patients With End-Stage Renal Disease on Hemodialysis	N/A
Completed	`NCT02694068` - Biological Determinants of Peritoneal Dialysis
Not yet recruiting	`NCT02832505` - Applications of MRI in Kidney Disease
Not yet recruiting	`NCT02590081` - Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients	Phase 4
Completed	`NCT01859884` - Optimizing Kidney Transplant Informed Consent	N/A
Completed	`NCT00509236` - Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)	Phase 3
Completed	`NCT02009514` - Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients	Phase 4
Not yet recruiting	`NCT06377293` - Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients	N/A
Completed	`NCT01528800` - Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients	Phase 2
Completed	`NCT01863914` - Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula	Phase 2
Withdrawn	`NCT06030050` - Animal Assisted Intervention for Hemodialysis Outpatients	N/A
Completed	`NCT04610593` - Effects of a Mindfulness-based Intervention in Stress, Pain and Quality of Life in People Undergoing Hemodialysis	N/A
Active, not recruiting	`NCT02755610` - Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis	N/A
Not yet recruiting	`NCT05931276` - CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes	Phase 3
Recruiting	`NCT03142529` - Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease	Phase 1/Phase 2
Completed	`NCT02342119` - Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation	N/A
Recruiting	`NCT05614115` - Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD	Phase 1
Recruiting	`NCT01111422` - Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients	Phase 4